Strong evidence for a link between the follistatin gene and polycystic ovary syndrome (PCOS) has recently been found in a well-designed large-scale study. Follistatin binds to activin and affects its functions, e.g. stimulation of FSH synthesis and secretion. Thus, it may play a role in the functional impairment of the FSHgranulosa cell axis in PCOS. In this study, we screened 64 Chinese patients with PCOS for mutations in the entire coding region (including the region encoding alternative carboxy-terminals) of the follistatin gene using polymerase chain reaction (PCR)-based single-stranded conformational polymorphism (SSCP) and DNA sequencing. However, we could not identify a single mutation of either the activating or inhibiting type, using these techniques. Therefore, it would appear that PCOS in the local Chinese population is not caused by mutations in the coding regions of the follistatin gene.
Introduction
of obesity and energy. They found evidence for linkage only with the CYP11A and follistatin genes. However, only the Polycystic ovary syndrome (PCOS) is a common endocrine linkage with follistatin gene remained significant after correcdisorder of premenopausal women, characterized by the prestion for multiple testing. Nevertheless, this study apparently ence of eight or more subcapsular follicular cysts of ഛ10 mm confirmed previous findings which in size and increased ovarian stroma (Polson et al., 1988;  demonstrated the linkage of CYP11A gene with PCOS. Franks, 1995) . It is a leading cause of female infertility and Follistatin is a single-chain glycosylated polypeptide that is associated with androgen excess, hirsutism, obesity and can bind to activin with high affinity and neutralize its increased risk for developing non-insulin-dependent diabetes biological action of stimulating the secretion of FSH and mellitus (Dahlgren et al., 1992; Dunaif, 1999) . Its prevalence increasing FSHβ mRNA levels (Carroll et al., 1989 ; Rivier may be up to 10% in women of reproductive age (Waterworth and Vale, 1991; Shimonaka et al., 1991) and may, therefore, et al., 1997) . It is highly prevalent within families, suggesting arrest folliculogenesis. Indeed, over-expression of follistatin in a genetic basis (Cooper et al., 1968; Carey et al., 1993;  Legro the transgenic mice resulted in the suppression of both serum et al., 1998) , but its precise mode of inheritance and molecular concentrations of FSH and ovarian folliculogenesis (Gou et al., basis remain unclear. 1998) , similar to the clinical features commonly found in Several genes involved in the biosynthesis of androgen, and PCOS patients. action of insulin and gonadotrophin have been examined as Follistatin is expressed in numerous tissues including the candidate genes for PCOS (Moller and Flier, 1988; Carey ovary, pituitary, adrenal cortex, and pancreas (Meunier et al., et al., 1994; Conway et al., 1994; Franks, 1995; Talbot et al., 1988; Shimasaki et al., 1989; Gospodarowicz and Lau, 1989; Dunaif Kogawa et al., 1991; Kaiser et al., 1992; Ogawa et al., 1993 Ogawa et al., ). et al., 1999 . These genes include those for the cholesterol The human cDNAs encoding follistatin have been cloned side-chain cleavage enzyme (CYP11A), 17 α-hydroxylase/ (Shimasaki et al., 1988) . There is a single follistatin gene that 17,20-lyase (CYP17), insulin, insulin receptor, and LH. Two can generate two mature mRNA transcripts by alternative of them, CYP11A and the insulin gene, variable number of splicing, thus encoding proteins of 315 (FS-315) and 288 (FStandem repeats (VNTR), have been proposed as predisposing 288) amino acid residues respectively (Shimasaki et al., genetic factors contributing to PCOS. However, neither of 1988). The FS-288, a carboxy-truncated variant with increased them has been widely accepted as a major cause for this biological potency (Inouye et al., 1991; Michel et al., 1993) , syndrome.
was found to bind strongly to heparin sulphate proteoglycans Recently, in a well-designed large-scale study, Urbanek et al. of the cell membrane, whereas FS-315 had little or no such (1999) tested for linkage and association between 37 candidate binding affinity. Furthermore, in the anterior pituitary cells, genes including those previously studied and PCOS. These FS-288 was more potent in suppressing FSH release (Sugino genes were carefully selected from those involved in the action of androgen, gonadotrophin and insulin, and also the regulation et al., 1993). This cell-associated protein was also found to ϩ8 to ϩ27
In each case the exon which is amplified is indicated on the left. The sequence of each pair of primers is indicated. The distance of each primer relative to the intron/exon junction is indicated by negative (primer located 5Ј to the junction) or positive (primer located 3Ј to the junction) values except the FS1 and FS12 which is 5Ј and 3Ј to the starting and ending amino acids respectively. The conditions of each hybridization step in PCR and the size of the amplified fragment are indicated for each pair of primers.
product was examined for fidelity by electrophoresis on a gel accelerate the uptake of activin into pituitary cells, leading to containing 2% agarose.
an increase in its degradation by lysosomal enzymes and thus playing a role in the activin clearance system (Hashimoto
Single-stranded conformational polymorphism (SSCP)
et al., 1997).
analysis and direct DNA sequencing
In this study, we screened the follistatin gene in PCOS
The PCR product (10 µl) was used for SSCP analysis. The SSCP patients in order to investigate the susceptibility of the follistatin was carried out as described previously with some gene to potentially pathogenic mutations.
modifications: gel concentration, 8-10%, temperature, 4°C, with the presence of 5% glycerol. DNA sequencing was carried out using a DNA sequencer (ABI Prism TM 377, PE Biosystem) with BigDye
Materials and methods
Terminator Cycle Sequencing Ready Reaction Kit (PE Biosystem, Patients Norwalk, Conn., USA). Chinese patients with PCOS (n ϭ 64) were recruited for this study. Their ages ranged from 19 to 38 years (25.6 Ϯ 6.7 years; mean Ϯ Results SD). The diagnosis of PCOS was based on the clinical features and laboratory examination. They had irregular menses (ഛ21 or ജ34
Patients' clinical data days), hirsutism, acne and obesity, together with multiple ovarian Clinical, biochemical and ultrasound parameters were meascysts detected by ultrasound. A fasting blood sample for serum FSH, ured in all the subjects studied. Of the 64 PCOS patients, 37 LH, oestradiol, testosterone and progesterone measurements was had only irregular menses, five had acne, two hirsutism, 12 obtained at 08:00 for every PCOS patient (Table I) . obesity, two acne and hirsutism, one acne and obesity, three DNA extraction and polymerase chain reaction (PCR) hirsutism and obesity, and two acne, hirsutism and obesity.
Genomic DNA was extracted from peripheral blood using standard
The body mass index (BMI ϭ weight/height 2 ) of these 27 procedures. Specific primers for PCR amplification of the exons are patients was 28.62 Ϯ 6.67 (mean Ϯ SD, range 16.48-39.86).
given in Table II . The PCR amplification was carried out in a total
The patients' hormonal parameters are shown in Table II. volume of 20 µl reaction mixture containing 1.5 mmol/l of MgCl 2 , Higher LH/FSH ratio (Ͼ3) was seen in most of the patients. 
Screening of the follistatin gene
Gaithersburg, MD, USA). The cycling profile consisted of denaturation All the exons of the gene (Figure 1) were successfully amplified at 94°C for 1 min, annealing at either 52°C or 65°C for 30 s (Table   by PCR in all patients using the primers with normal sequence. II) and extension at 72°C for 30 s, except for the first cycle when denaturation was extended to 5 min. After PCR, 5 µl of the amplified Therefore, no deletion appeared to exist in any of the exons. The size of PCR products was 137-284 bp (Table II) . The implicating follistatin gene in the disease process. The focus of this study was therefore to screen the follistatin gene for PCR products were screened in duplicate for mutations by SSCP analysis. There was no mobility shift in any of the PCR mutations in PCOS patients for a better understanding of the pathophysiology of PCOS, and for the prevalence of mutations products, suggesting the absence of polymorphisms/mutations in the exons. DNA sequencing was carried out randomly in in the follistatin gene contributing to its development. Primers were designed to amply the coding regions of four to seven samples for each amplified exon with forward and reverse primers to verify the SSCP results, and again no follistatin gene (Shimasaki et al., 1988 ; Figure 1 ), including the two alternative splicing regions and all the splicing junctions mutations or polymorphisms were detected.
in which any nucleotide transition might result in alternative splicing, affecting relative abundance of the two isoforms
Discussion
of follistatin in particular. However, using the PCR-SSCP Follistatin is a high-affinity binding protein that modulates the technique, we were unable to detect any mutations or polybioactivity of activin in vitro and in vivo (Mather et al., 1997;  morphisms in the entire coding regions of the follistatin gene. Guo et al., 1998) . Activin enhances FSH-induced aromatase
The SSCP technique can detect 70-90% of mutations in PCR activity (Xiao et al., 1990 , LH binding site activity products (Hayashi, 1991; Michaud et al., 1992) , and has been (Hutchinson et al., 1987) , and progesterone production (Xiao successfully used in our laboratory for mutation searching in et al., 1992a,b) , and may play a role in preventing premature various other genes (Liao et al., , 1999 ; luteinization of the ovarian follicles. In the rat model, follistatin Chen et al., 2000) . Furthermore, DNA sequencing results modifies FSH action on the granulosa cells as evidenced by confirmed those of SSCP. Therefore, these results suggest that inhibition of aromatase activity and inhibin production, while mutations in the coding regions of follistatin gene are unlikely it enhances progesterone production . It to be a common cause of PCOS in the women studied. reverses the enhancing effect of activin on the FSH-stimulated Unfortunately, the regulation region of the gene could not be steroidogenesis and inhibin production, and inhibits the activinstudied because the sequence is still unknown. induced FSH receptor number (Xiao et al., 1992b) and basal
In conclusion, we were unable to detect any mutation of inhibin production by granulosa cells (Xiao et al., 1992a) .
the activating or inhibiting type in the entire coding region of Thus, follistatin may modulate the granulosa cell function follistatin gene in 64 patients with PCOS. Therefore, mutations in an autocrine/paracrine fashion through the binding and in the coding regions of the follistatin gene may not be a neutralization of activin action, and this is likely to favour the common cause of PCOS in the population studied. However, process of follicular luteinization or atresia. Over-expression it is possible that mutations may reside in the regulation region of follistatin or an increase in its functional activity would of the gene, which should be screened once its sequence is therefore be expected to arrest follicular development, increase known. Furthermore, it would be of great interest to investigate ovarian androgen production, and reduce circulating FSH the presence of mutations in PCOS patients in other ethnic concentrations, these are characteristic features of PCOS.
populations, especially of European origin, as it was in this Indeed, when a high amount of follistatin was introduced in population that the linkage between the follistatin gene and the transgenic female mice, some of them became infertile PCOS was established (Urbanek et al., 1999) . and showed small ovaries due to the blockage of folliculogenesis and suppressed serum FSH concentrations (Guo et al., 1998) .
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